Correlation Between Zentalis Pharmaceuticals and Molecular Partners
Can any of the company-specific risk be diversified away by investing in both Zentalis Pharmaceuticals and Molecular Partners at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Zentalis Pharmaceuticals and Molecular Partners into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Zentalis Pharmaceuticals Llc and Molecular Partners AG, you can compare the effects of market volatilities on Zentalis Pharmaceuticals and Molecular Partners and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Zentalis Pharmaceuticals with a short position of Molecular Partners. Check out your portfolio center. Please also check ongoing floating volatility patterns of Zentalis Pharmaceuticals and Molecular Partners.
Diversification Opportunities for Zentalis Pharmaceuticals and Molecular Partners
0.13 | Correlation Coefficient |
Average diversification
The 3 months correlation between Zentalis and Molecular is 0.13. Overlapping area represents the amount of risk that can be diversified away by holding Zentalis Pharmaceuticals Llc and Molecular Partners AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Molecular Partners and Zentalis Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Zentalis Pharmaceuticals Llc are associated (or correlated) with Molecular Partners. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Molecular Partners has no effect on the direction of Zentalis Pharmaceuticals i.e., Zentalis Pharmaceuticals and Molecular Partners go up and down completely randomly.
Pair Corralation between Zentalis Pharmaceuticals and Molecular Partners
Given the investment horizon of 90 days Zentalis Pharmaceuticals Llc is expected to under-perform the Molecular Partners. In addition to that, Zentalis Pharmaceuticals is 1.84 times more volatile than Molecular Partners AG. It trades about -0.36 of its total potential returns per unit of risk. Molecular Partners AG is currently generating about 0.04 per unit of volatility. If you would invest 506.00 in Molecular Partners AG on November 5, 2024 and sell it today you would earn a total of 10.00 from holding Molecular Partners AG or generate 1.98% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 95.0% |
| Values | Daily Returns |
Zentalis Pharmaceuticals Llc vs. Molecular Partners AG
Performance |
| Timeline |
| Zentalis Pharmaceuticals |
| Molecular Partners |
Zentalis Pharmaceuticals and Molecular Partners Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Zentalis Pharmaceuticals and Molecular Partners
The main advantage of trading using opposite Zentalis Pharmaceuticals and Molecular Partners positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Zentalis Pharmaceuticals position performs unexpectedly, Molecular Partners can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Molecular Partners will offset losses from the drop in Molecular Partners' long position.| Zentalis Pharmaceuticals vs. Sana Biotechnology | Zentalis Pharmaceuticals vs. Olema Pharmaceuticals | Zentalis Pharmaceuticals vs. Cullinan Oncology LLC | Zentalis Pharmaceuticals vs. Monte Rosa Therapeutics |
| Molecular Partners vs. CytomX Therapeutics | Molecular Partners vs. Instil Bio | Molecular Partners vs. Spero Therapeutics | Molecular Partners vs. Assembly Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Other Complementary Tools
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |